How Atsena Got Its Gene Therapy To Spread Subretinally To Treat XLRS
UF researcher Sanford Boye, co-founder and adviser of UF Startup Atsena Therapeutics, shared insights into how the company developed its gene therapy to achieve subretinal spread for treating XLRS.
Solid Biosciences Announces Collaboration With Mayo Clinic To Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies
Solid Biosciences Inc., which acquired UF Startup AavantiBio, has partnered with Mayo Clinic to advance an AAV gene therapy platform for next-generation treatments targeting genetic cardiomyopathies and channelopathies linked to sudden cardiac death.
Source Agriculture Corp. Makes Strategic Investment in Ascribe Bioscience To Advance Sustainable Crop Protection Solutions
Source Agriculture Corp., an innovative agri-tech investment firm, announced a strategic investment in UF Startup Ascribe Bioscience, a cutting-edge company dedicated to developing sustainable crop protection solutions.
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer
UF Startup Cannabix Technologies Inc. reports that it has received a positive certification test report from the globally recognized laboratory CEcert GmbH, based in Germany, for its Breath Logix autonomous, wall-mounted alcohol breathalyzer device.
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction
UF Startup RTI Surgical announced the enrollment of the first patient in ADMIRE, a study designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis in implant-based breast reconstruction.
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
UF Startup Kate Therapeutics, a gene therapy specialist, is being acquired by Novartis in a deal worth up to $1.1 billion. This acquisition aligns with Novartis’s efforts to deliver treatments for neuromuscular disorders and fits into the pharma’s strategy to expand its new modality pipeline, ensuring long-term business sustainability.
Kriya Announces Publication of Preclinical Data for Its Investigational AAV-FGF21 Gene Therapy Demonstrating Durable Reversal of Liver Fibrosis
UF Startup Kriya Therapeutics, a biopharmaceutical company developing gene therapies to address common diseases affecting millions of people around the world, announced the publication of preclinical data for its investigational AAV-FGF21 gene therapy.
Solid Biosciences To Present at the Jefferies London Healthcare Conference
Solid Biosciences Inc., a biotechnology company that acquired UF startup AavantiBio, announced that Bo Combo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will present at the Jefferies London Healthcare Conference on November 20.
NovaBone Secures FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications
UF Startup NovaBone Products announced that it has received FDA clearance for its bioactive synthetic bone graft, NovaBone Putty, which is now expandable for use in the intervertebral disc space.
Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for ATSN-101
Atsena Therapeutics Inc., a UF Startup, has entered into an exclusive license agreement with Nippon Shinyaku Co., Ltd. for the commercialization of ATSN-101 in the United States, and for its development and commercialization in Japan.
